Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption

Authors: Mia Tyrstrup, Eva Melander, Katarina Hedin, Anders Beckman, Sigvard Mölstad

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

The majority of antibiotics consumed in developed countries are prescribed in primary care. However, little is known about resistance levels in the primary care population.

Method

Nasopharyngeal cultures were obtained from children, 0-10 years of age, seeking care at their Primary Health Care Centre with symptoms of respiratory tract infection. Parental questionnaires were used to retrieve information about the child’s previous antibiotic consumption.

Result

Cultures from 340 children were gathered. The level of resistant Haemophilus influenzae was low and the prevalence of penicillin non-susceptible pneumococci (PNSP MIC ≥ 0.125 mg/L) was 6% compared to 10% (p = 0.31) in corresponding cultures from children diagnosed at the local clinical microbiology laboratory. Antibiotic treatment within the previous 4 weeks predisposed for resistant bacteria in the nasopharynx, OR: 3.08, CI 95% (1.13-8.42).

Conclusion

Low prevalence of PNSP supports the use of phenoxymethylpenicillin as empirical treatment for childhood upper respiratory tract infections attending primary care in our setting. It is important that studies on resistance are performed in primary care populations to evaluate data from microbiological laboratories. Recent antibiotic treatment increases risk of bacterial resistance in children and continuous work to reduce unnecessary antibiotic prescribing should be prioritised.
Appendix
Available only for authorised users
Literature
2.
go back to reference Musher DM. Infections caused by Streptococcus Pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis Off Publ Infect Dis Soc Am. 1992;14:801–7.CrossRef Musher DM. Infections caused by Streptococcus Pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis Off Publ Infect Dis Soc Am. 1992;14:801–7.CrossRef
3.
go back to reference Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589–95.PubMedPubMedCentral Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589–95.PubMedPubMedCentral
6.
go back to reference Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus Pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 1980;142:923–33.CrossRefPubMed Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus Pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 1980;142:923–33.CrossRefPubMed
7.
go back to reference Pebody RG, Morgan O, Choi Y, George R, Hussain M, Andrews N. Use of antibiotics and risk factors for carriage of Streptococcus Pneumoniae: a longitudinal household study in the United Kingdom. Epidemiol Infect. 2009;137:555–61.CrossRefPubMed Pebody RG, Morgan O, Choi Y, George R, Hussain M, Andrews N. Use of antibiotics and risk factors for carriage of Streptococcus Pneumoniae: a longitudinal household study in the United Kingdom. Epidemiol Infect. 2009;137:555–61.CrossRefPubMed
8.
go back to reference van Deursen AMM, van den Bergh MR, Sanders EAM. Carriage pilot study group. Carriage of Streptococcus Pneumoniae in asymptomatic, community-dwelling elderly in the Netherlands. Vaccine. 2016;34:4–6.CrossRefPubMed van Deursen AMM, van den Bergh MR, Sanders EAM. Carriage pilot study group. Carriage of Streptococcus Pneumoniae in asymptomatic, community-dwelling elderly in the Netherlands. Vaccine. 2016;34:4–6.CrossRefPubMed
9.
11.
go back to reference Kristinsson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist Larchmt N. 1995;1:121–5.CrossRef Kristinsson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist Larchmt N. 1995;1:121–5.CrossRef
12.
go back to reference Arason VA, Kristinsson KG, Sigurdsson JA, Stefánsdóttir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ. 1996;313:387–91.CrossRefPubMedPubMedCentral Arason VA, Kristinsson KG, Sigurdsson JA, Stefánsdóttir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ. 1996;313:387–91.CrossRefPubMedPubMedCentral
13.
go back to reference Melander E, Ekdahl K, Jönsson G, Mölstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J. 2000;19:1172–7.CrossRefPubMed Melander E, Ekdahl K, Jönsson G, Mölstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J. 2000;19:1172–7.CrossRefPubMed
14.
go back to reference Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet Lond Engl. 2005;365:579–87.CrossRef Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet Lond Engl. 2005;365:579–87.CrossRef
15.
go back to reference Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS Acta Pathol Microbiol Immunol Scand. 1994;102:227–35.CrossRef Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS Acta Pathol Microbiol Immunol Scand. 1994;102:227–35.CrossRef
16.
go back to reference Melander E, Ekdahl K, Hansson HB, Kamme C, Laurell M, Nilsson P, et al. Introduction and clonal spread of penicillin- and trimethoprim/sulfamethoxazole-resistant Streptococcus Pneumoniae, serotype 9V, in southern Sweden. Microb Drug Resist Larchmt N. 1998;4:71–8.CrossRef Melander E, Ekdahl K, Hansson HB, Kamme C, Laurell M, Nilsson P, et al. Introduction and clonal spread of penicillin- and trimethoprim/sulfamethoxazole-resistant Streptococcus Pneumoniae, serotype 9V, in southern Sweden. Microb Drug Resist Larchmt N. 1998;4:71–8.CrossRef
17.
go back to reference Skovbjerg S, Söderström A, Hynsjö L, Normark BH, Ekdahl K, Ahrén C. Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers. Scand J Infect Dis. 2013;45(4):279–84. Skovbjerg S, Söderström A, Hynsjö L, Normark BH, Ekdahl K, Ahrén C. Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers. Scand J Infect Dis. 2013;45(4):279–84.
19.
go back to reference Van Eldere J, Slack MPE, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014;14:1281–92.CrossRefPubMed Van Eldere J, Slack MPE, Ladhani S, Cripps AW. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis. 2014;14:1281–92.CrossRefPubMed
20.
go back to reference Fontanals D, Bou R, Pons I, Sanfeliu I, Domínguez A, Pineda V, et al. Prevalence of Haemophilus influenzae carriers in the Catalan preschool population. Working group on invasive disease caused by Haemophilus influenzae. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2000;19:301–4.CrossRef Fontanals D, Bou R, Pons I, Sanfeliu I, Domínguez A, Pineda V, et al. Prevalence of Haemophilus influenzae carriers in the Catalan preschool population. Working group on invasive disease caused by Haemophilus influenzae. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2000;19:301–4.CrossRef
21.
go back to reference Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28:43–8.CrossRefPubMed Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, et al. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2009;28:43–8.CrossRefPubMed
22.
go back to reference Thomas WJ, McReynolds JW, Mock CR, Bailey DW. Letter: Ampicillin-resistant Haemophilus influenzae meningitis. Lancet Lond Engl. 1974;1:313.CrossRef Thomas WJ, McReynolds JW, Mock CR, Bailey DW. Letter: Ampicillin-resistant Haemophilus influenzae meningitis. Lancet Lond Engl. 1974;1:313.CrossRef
24.
go back to reference Beekmann SE, Heilmann KP, Richter SS, García-de-Lomas J, Doern GV, GRASP Study Group. Antimicrobial resistance in Streptococcus Pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group a beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents. 2005;25:148–56.CrossRefPubMed Beekmann SE, Heilmann KP, Richter SS, García-de-Lomas J, Doern GV, GRASP Study Group. Antimicrobial resistance in Streptococcus Pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group a beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents. 2005;25:148–56.CrossRefPubMed
29.
go back to reference Sánchez-Tatay D, Arroyo LA, Tarragó D, Lirola MJ, Porras A, Fenoll A, et al. Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2008;14:797–801. Sánchez-Tatay D, Arroyo LA, Tarragó D, Lirola MJ, Porras A, Fenoll A, et al. Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2008;14:797–801.
31.
go back to reference Angoulvant F, Cohen R, Doit C, Elbez A, Werner A, Béchet S, et al. Trends in antibiotic resistance of Streptococcus Pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis. 2015;15:236.CrossRefPubMedPubMedCentral Angoulvant F, Cohen R, Doit C, Elbez A, Werner A, Béchet S, et al. Trends in antibiotic resistance of Streptococcus Pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis. 2015;15:236.CrossRefPubMedPubMedCentral
32.
go back to reference Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman SL, Kleinman K, Goldmann D, et al. Antibiotic-resistant Streptococcus Pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003;112:862–9.CrossRefPubMed Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman SL, Kleinman K, Goldmann D, et al. Antibiotic-resistant Streptococcus Pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics. 2003;112:862–9.CrossRefPubMed
33.
go back to reference Felmingham D, Grüneberg RN, Group >the Alexander Project. The Alexander project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother. 2000;45:191–203.CrossRefPubMed Felmingham D, Grüneberg RN, Group >the Alexander Project. The Alexander project 1996–1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother. 2000;45:191–203.CrossRefPubMed
34.
go back to reference Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.CrossRefPubMed Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.CrossRefPubMed
35.
go back to reference Ghaffar F, Muniz LS, Kathy K, Smith JL, Shouse T, Davis P, et al. Effects of large dosages of amoxicillin/Clavulanate or Azithromycin on nasopharyngeal carriage of Streptococcus Pneumoniae, Haemophilus influenzae, nonpneumococcal α-hemolytic streptococci, and Staphylococcus Aureus in children with acute Otitis media. Clin Infect Dis. 2002;34:1301–9.CrossRefPubMed Ghaffar F, Muniz LS, Kathy K, Smith JL, Shouse T, Davis P, et al. Effects of large dosages of amoxicillin/Clavulanate or Azithromycin on nasopharyngeal carriage of Streptococcus Pneumoniae, Haemophilus influenzae, nonpneumococcal α-hemolytic streptococci, and Staphylococcus Aureus in children with acute Otitis media. Clin Infect Dis. 2002;34:1301–9.CrossRefPubMed
36.
go back to reference Melander E, Mölstad S, Persson K, Hansson HB, Söderström M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus Pneumoniae in children. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 1998;17:834–8.CrossRef Melander E, Mölstad S, Persson K, Hansson HB, Söderström M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus Pneumoniae in children. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 1998;17:834–8.CrossRef
37.
go back to reference Arason VA, Sigurdsson JA, Erlendsdottir H, Gudmundsson S, Kristinsson KG. The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up. Microb Drug Resist Larchmt N. 2006;12:169–76.CrossRef Arason VA, Sigurdsson JA, Erlendsdottir H, Gudmundsson S, Kristinsson KG. The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up. Microb Drug Resist Larchmt N. 2006;12:169–76.CrossRef
38.
go back to reference Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.CrossRefPubMed Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.CrossRefPubMed
39.
go back to reference Gisselsson-Solen M, Hermansson A, Melhus Å. Individual-level effects of antibiotics on colonizing otitis pathogens in the nasopharynx. Int J Pediatr Otorhinolaryngol. 2016;88:17–21.CrossRefPubMed Gisselsson-Solen M, Hermansson A, Melhus Å. Individual-level effects of antibiotics on colonizing otitis pathogens in the nasopharynx. Int J Pediatr Otorhinolaryngol. 2016;88:17–21.CrossRefPubMed
40.
go back to reference Eliasson I, Holst E, Mölstad S, Kamme C. Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics. Am J Med. 1990;88:51S–5S.CrossRefPubMed Eliasson I, Holst E, Mölstad S, Kamme C. Emergence and persistence of beta-lactamase-producing bacteria in the upper respiratory tract in children treated with beta-lactam antibiotics. Am J Med. 1990;88:51S–5S.CrossRefPubMed
41.
go back to reference Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335:429.CrossRefPubMedPubMedCentral Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. BMJ. 2007;335:429.CrossRefPubMedPubMedCentral
42.
go back to reference Seaton RA, Steinke DT, Phillips G, MacDonald T, Davey PG. Community antibiotic therapy, hospitalization and subsequent respiratory tract isolation of Haemophilus influenzae resistant to amoxycillin: a nested case–control study. J Antimicrob Chemother. 2000;46:307–9.CrossRefPubMed Seaton RA, Steinke DT, Phillips G, MacDonald T, Davey PG. Community antibiotic therapy, hospitalization and subsequent respiratory tract isolation of Haemophilus influenzae resistant to amoxycillin: a nested case–control study. J Antimicrob Chemother. 2000;46:307–9.CrossRefPubMed
43.
go back to reference Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus Pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2000;31:477–81.CrossRef Varon E, Levy C, De La Rocque F, Boucherat M, Deforche D, Podglajen I, et al. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus Pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections. Clin Infect Dis Off Publ Infect Dis Soc Am. 2000;31:477–81.CrossRef
44.
go back to reference Dabernat H, Geslin P, Megraud F, Bégué P, Boulesteix J, Dubreuil C, et al. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus Pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother. 1998;41:253–8.CrossRefPubMed Dabernat H, Geslin P, Megraud F, Bégué P, Boulesteix J, Dubreuil C, et al. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus Pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother. 1998;41:253–8.CrossRefPubMed
45.
go back to reference Jensen-Fangel S, Mohey R, Johnsen SP, Andersen PL, Sørensen HT, Ostergaard L. Gender differences in hospitalization rates for respiratory tract infections in Danish youth. Scand J Infect Dis 2004;36:31–6. Jensen-Fangel S, Mohey R, Johnsen SP, Andersen PL, Sørensen HT, Ostergaard L. Gender differences in hospitalization rates for respiratory tract infections in Danish youth. Scand J Infect Dis 2004;36:31–6.
46.
go back to reference Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh study. JAMA. 1974;227:164–9.CrossRefPubMed Monto AS, Ullman BM. Acute respiratory illness in an American community. The Tecumseh study. JAMA. 1974;227:164–9.CrossRefPubMed
47.
go back to reference Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101:1845–63.CrossRefPubMed Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101:1845–63.CrossRefPubMed
Metadata
Title
Children with respiratory tract infections in Swedish primary care; prevalence of antibiotic resistance in common respiratory tract pathogens and relation to antibiotic consumption
Authors
Mia Tyrstrup
Eva Melander
Katarina Hedin
Anders Beckman
Sigvard Mölstad
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2703-3

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.